Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 7 | 2024 | 104 | 4.300 |
Why?
|
| Vaginosis, Bacterial | 6 | 2024 | 29 | 4.060 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2023 | 17 | 3.170 |
Why?
|
| Vagina | 4 | 2024 | 33 | 1.700 |
Why?
|
| HIV Infections | 4 | 2022 | 488 | 1.530 |
Why?
|
| Social Media | 2 | 2022 | 50 | 1.410 |
Why?
|
| Menstrual Hygiene Products | 3 | 2024 | 4 | 1.220 |
Why?
|
| Toilet Facilities | 1 | 2024 | 2 | 0.960 |
Why?
|
| Rain | 1 | 2024 | 3 | 0.960 |
Why?
|
| Menstruation | 1 | 2024 | 4 | 0.890 |
Why?
|
| Students | 1 | 2024 | 52 | 0.840 |
Why?
|
| Insurance, Health | 1 | 2022 | 23 | 0.820 |
Why?
|
| Herpes Genitalis | 1 | 2022 | 6 | 0.820 |
Why?
|
| Circumcision, Female | 1 | 2022 | 2 | 0.810 |
Why?
|
| Circumcision, Male | 1 | 2022 | 8 | 0.810 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2024 | 55 | 0.780 |
Why?
|
| Forecasting | 1 | 2020 | 103 | 0.690 |
Why?
|
| Public Health | 1 | 2020 | 68 | 0.690 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 158 | 0.670 |
Why?
|
| Adolescent | 4 | 2024 | 2307 | 0.550 |
Why?
|
| Female | 10 | 2024 | 15704 | 0.550 |
Why?
|
| Young Adult | 4 | 2024 | 2069 | 0.500 |
Why?
|
| Chicago | 3 | 2024 | 939 | 0.480 |
Why?
|
| Humans | 12 | 2024 | 28395 | 0.480 |
Why?
|
| Prospective Studies | 3 | 2024 | 1804 | 0.420 |
Why?
|
| Herpesvirus 2, Human | 2 | 2022 | 7 | 0.410 |
Why?
|
| Kenya | 2 | 2023 | 12 | 0.390 |
Why?
|
| Adult | 6 | 2024 | 8097 | 0.390 |
Why?
|
| Sexual Partners | 2 | 2022 | 17 | 0.380 |
Why?
|
| Lactobacillus | 3 | 2020 | 19 | 0.330 |
Why?
|
| Male | 5 | 2022 | 15269 | 0.300 |
Why?
|
| Sanitation | 1 | 2024 | 2 | 0.240 |
Why?
|
| Hygiene | 1 | 2024 | 12 | 0.240 |
Why?
|
| Enterobacteriaceae | 1 | 2024 | 43 | 0.230 |
Why?
|
| Bacteria | 1 | 2024 | 74 | 0.230 |
Why?
|
| Universities | 1 | 2024 | 41 | 0.220 |
Why?
|
| Schools | 1 | 2023 | 46 | 0.210 |
Why?
|
| Poverty | 1 | 2024 | 100 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 329 | 0.210 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 14 | 0.210 |
Why?
|
| Urban Population | 1 | 2024 | 157 | 0.210 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2022 | 22 | 0.200 |
Why?
|
| Insurance Coverage | 1 | 2022 | 16 | 0.200 |
Why?
|
| Pilot Projects | 1 | 2024 | 439 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 185 | 0.190 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 110 | 0.190 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 68 | 0.190 |
Why?
|
| Syphilis | 1 | 2020 | 3 | 0.180 |
Why?
|
| Gonorrhea | 1 | 2020 | 7 | 0.180 |
Why?
|
| Chlamydia Infections | 1 | 2020 | 7 | 0.180 |
Why?
|
| Fusobacteria | 1 | 2020 | 2 | 0.180 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 932 | 0.170 |
Why?
|
| Pandemics | 1 | 2022 | 260 | 0.170 |
Why?
|
| Penis | 1 | 2020 | 82 | 0.160 |
Why?
|
| Prevalence | 1 | 2020 | 467 | 0.160 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 1215 | 0.150 |
Why?
|
| Cervix Uteri | 1 | 2016 | 13 | 0.130 |
Why?
|
| Papillomaviridae | 1 | 2016 | 18 | 0.130 |
Why?
|
| United States | 1 | 2022 | 2196 | 0.130 |
Why?
|
| Metagenome | 1 | 2015 | 17 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2015 | 46 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 58 | 0.120 |
Why?
|
| Coinfection | 1 | 2015 | 22 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2016 | 1926 | 0.100 |
Why?
|
| Time Factors | 1 | 2015 | 1490 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 1858 | 0.080 |
Why?
|
| Risk Factors | 1 | 2015 | 2408 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 54 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 40 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 116 | 0.030 |
Why?
|